SEC Form 4 · accession 0001209191-17-009529
Spring Bank Pharmaceuticals, Inc. · SBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nezam H. Afdhal
Officer — Chief Medical Officer
Period of report
Feb 9, 2017
Accepted (ET)
Feb 10, 2017 · 4:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001566373
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $7.66 | Feb 9, 2017 | A | 40,000 | A | — | Feb 9, 2027 | Cpmmon Stock | 40,000 | 40,000 | D |
Explanation of responses
- F1This option was granted on February 9, 2017, with 25% of the shares subject to the option vesting on January 1, 2018 and the remaining 75% of the shares subject to the option vesting in 36 equal monthly installments thereafter.